Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro

Background: One of the therapeutic limitations of the use of doxorubicin (DOX) as an anticancer drug is its cardiotoxicity. Its hydrophilicity also causes difficulties in achieving sustained release. The simultaneous delivery with the well-known natural antioxidant quercetin could ameliorate its car...

Descripción completa

Detalles Bibliográficos
Autores principales: Voycheva, Christina, Popova, Teodora, Slavkova, Marta, Tzankova, Virginia, Stefanova, Denitsa, Tzankova, Diana, Spassova, Ivanka, Kovacheva, Daniela, Tzankov, Borislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295274/
https://www.ncbi.nlm.nih.gov/pubmed/37370568
http://dx.doi.org/10.3390/bioengineering10060637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295274/
https://www.ncbi.nlm.nih.gov/pubmed/37370568
http://dx.doi.org/10.3390/bioengineering10060637

Ejemplares similares